Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Regarding the Plan to Achieve Compliance with the Continued Listing Criteria
Notice Regarding Application for Transition to the TSE Standard Market
December 2025 Monthly KPI Fiscal Year Ending October 2026
Notice Concerning Agreement Termination Regarding Stock Transfer Option between Major Shareholder and Former Representative Director, President CEO
Notice Regarding Distribution of Surplus (Dividend)
Notice Concerning Partial Amendments to the Articles of Incorporation
Notice Regarding Policy for Transition to the TSE Standard Market
[Summary]Consolidated Financial Results for the Fiscal Year Ended October 31, 2025(Under Japanese GAAP)
Notice Concerning the Write-Down of Deferred Tax Assets and Difference between Consolidated Financial Forecasts and Actual Results
October 2025 Monthly KPI Fiscal Year Ending October 2025
CellSource’s Blood-derived Processing Service Introduced at Hyogo Medical University Hospital, Department of Orthopedic Surgery
Notice Concerning Selection as Loan Margin Trading Issue
September 2025 Monthly KPI Fiscal Year Ending October 2025
Notice Concerning Revisions to Full-Year Financial Results Forecasts
[Summary]Consolidated Financial Results for the Nine Months Ended July 31, 2025 (Under Japanese GAAP)
Earnings Presentation Q3 FY10 2025
CellSource and Juntendo University Announce Research Findings on New Therapeutic Possibilities for Chronic Cerebral Infarction
CellSource and KAKEN PHARMACEUTICAL Initiate Discussions Toward a New Collaboration Framework
CellSource and Solallis Bio Enter into Comprehensive Business Alliance Agreement in the Regenerative Medicine Field
July 2025 Monthly KPI Fiscal Year Ending October 2025